LU85331A1 - Nouvelle association medicamenteuse pour le traitement de l'hypertension - Google Patents

Nouvelle association medicamenteuse pour le traitement de l'hypertension Download PDF

Info

Publication number
LU85331A1
LU85331A1 LU85331A LU85331A LU85331A1 LU 85331 A1 LU85331 A1 LU 85331A1 LU 85331 A LU85331 A LU 85331A LU 85331 A LU85331 A LU 85331A LU 85331 A1 LU85331 A1 LU 85331A1
Authority
LU
Luxembourg
Prior art keywords
compound
pharmaceutically acceptable
composition according
dergocrine
component
Prior art date
Application number
LU85331A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU85331A1 publication Critical patent/LU85331A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU85331A 1983-04-22 1984-04-20 Nouvelle association medicamenteuse pour le traitement de l'hypertension LU85331A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22
DE3314607 1983-04-22

Publications (1)

Publication Number Publication Date
LU85331A1 true LU85331A1 (fr) 1984-11-28

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85331A LU85331A1 (fr) 1983-04-22 1984-04-20 Nouvelle association medicamenteuse pour le traitement de l'hypertension

Country Status (27)

Country Link
US (2) US4617306A (sv)
JP (1) JPS59205318A (sv)
AT (1) AT393625B (sv)
AU (1) AU571218B2 (sv)
BE (1) BE899434A (sv)
CA (1) CA1218932A (sv)
CH (1) CH658992A5 (sv)
CY (1) CY1499A (sv)
DD (1) DD217712A5 (sv)
DK (1) DK165965C (sv)
FR (1) FR2544614B1 (sv)
GB (1) GB2138678B (sv)
GR (1) GR81973B (sv)
HK (1) HK100289A (sv)
HU (1) HU192050B (sv)
IE (1) IE57468B1 (sv)
IL (1) IL71601A (sv)
IT (1) IT1199114B (sv)
LU (1) LU85331A1 (sv)
MY (1) MY100397A (sv)
NL (1) NL188891C (sv)
NZ (1) NZ207917A (sv)
PH (1) PH20922A (sv)
PT (1) PT78455B (sv)
SE (1) SE465751B (sv)
SG (1) SG53889G (sv)
ZA (1) ZA842993B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159604B1 (en) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
EP1027885B1 (en) * 1999-02-09 2008-07-09 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (sv) * 1966-06-24 1967-10-16
SE351565B (sv) * 1967-08-17 1972-12-04 Sandoz Ag
NO145262C (no) * 1975-05-31 1982-02-17 Sandoz Ag Fremgangsmaate for fremstilling av en stabil loesning av ergotalkaloider eller deres salter
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Also Published As

Publication number Publication date
HK100289A (en) 1989-12-29
IT8448082A0 (it) 1984-04-20
GB2138678B (en) 1986-11-05
SE8402199L (sv) 1984-10-23
GB2138678A (en) 1984-10-31
PT78455A (en) 1984-05-01
AT393625B (de) 1991-11-25
GB8410363D0 (en) 1984-05-31
DK201884A (da) 1984-10-23
NL188891C (nl) 1992-11-02
JPS59205318A (ja) 1984-11-20
SE465751B (sv) 1991-10-28
JPH0564124B2 (sv) 1993-09-14
US4797404A (en) 1989-01-10
DK201884D0 (da) 1984-04-18
DK165965B (da) 1993-02-22
FR2544614B1 (fr) 1987-08-21
IL71601A (en) 1988-12-30
IE840977L (en) 1984-10-22
SE8402199D0 (sv) 1984-04-19
SG53889G (en) 1989-12-08
IL71601A0 (en) 1984-07-31
DK165965C (da) 1993-07-26
PT78455B (en) 1986-05-27
MY100397A (en) 1990-09-17
FR2544614A1 (fr) 1984-10-26
CA1218932A (en) 1987-03-10
GR81973B (sv) 1984-12-12
HU192050B (en) 1987-05-28
AU571218B2 (en) 1988-04-14
US4617306A (en) 1986-10-14
NL8401155A (nl) 1984-11-16
ZA842993B (en) 1985-11-27
CH658992A5 (de) 1986-12-31
BE899434A (fr) 1984-10-16
DD217712A5 (de) 1985-01-23
IE57468B1 (en) 1993-01-27
NZ207917A (en) 1988-05-30
ATA133784A (de) 1991-05-15
HUT37889A (en) 1986-03-28
AU2712084A (en) 1984-10-25
CY1499A (en) 1990-08-03
IT1199114B (it) 1988-12-30
PH20922A (en) 1987-06-05

Similar Documents

Publication Publication Date Title
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
JPS58219117A (ja) 脳不全症の処置方法
JP2007518755A (ja) モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物
EP1988898A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
JP6154878B2 (ja) アタザナビルを含む錠剤組成物
CA2123232C (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
FR2896157A1 (fr) Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
KR100209201B1 (ko) 1,4-디히드로피리딘 유도체를 함유하는 고체 분산 정제 및 그의 제조방법
KR20170061493A (ko) 피마살탄의 신규 염
FR2524314A1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
US20060030602A1 (en) (S)-amlodipine malate
LU85331A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
CA2333001A1 (en) Benzofuroxan derivatives and their use in treating angina pectoris
JPS61183225A (ja) ９，１０‐ジヒドロ麦角アルカロイド含有医薬組成物
MXPA02003452A (es) Tratamiento de combinacion de esclerosis multiple (em), otras condiciones de desmielinacion y neuropatia periferica, especialmente neuropatias dolorosas y neuropatia diabetica.
EP1682124B1 (fr) Compositions pharmaceutiques a base de sel d'idazoxan ou d´un de ses polymorphes
EP0950050B1 (fr) Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2605222A1 (fr) Agent therapeutique a base de nitrate de n-(2-hydroxyethyl) nicotinamide pour le traitement de troubles associes a l'ischemie cerebrale
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
US20200230084A1 (en) Methods of treating disease with dichlorphenamide
JPH05229944A (ja) モノアミノオキシダーゼｂ阻害因子
CH660189A5 (fr) Sels de dioxyde de benzothiazine cristallin et compositions pharmaceutiques les contenant.
FR2700114A1 (fr) Application de la lamotrigine dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2881049A1 (fr) Medicament destine a etre administre par voie orale comprenant un inhibiteur de la cyclo-oxygenase-2, et son procede de preparation
MXPA06008113A (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist